
ReShape Lifesciences (RSLS) Earnings Dates & Reports
ReShape Lifesciences (RSLS) Most Recent Earnings
Report Date
Period EndingQ1 2024
Est. EPS-$232
Actual EPS-$130.50
EarningsBeat
ReShape Lifesciences (RSLS) Earnings
View the latest ReShape Lifesciences (RSLS) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in ReShape Lifesciences (RSLS)
Order type
Buy in
Order amount
Est. shares
0 shares
ReShape Lifesciences (RSLS) Earnings per Share (EPS) History
Signup for full accessBrowse free
ReShape Lifesciences (RSLS) Latest Earnings
The value each RSLS share was expected to gain vs. the value each share gained.
ReShape Lifesciences (RSLS) reported its most recent earnings on for Q1 2024, posting earnings per share (EPS) of -$130.50. This exceeded analysts' expectations of -$232 by 43.75%, marking a Beat.
For comparison, ReShape Lifesciences reported EPS of -$2,262 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.
ReShape Lifesciences (RSLS) Earnings History
ReShape Lifesciences (RSLS) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the ReShape Lifesciences’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
ReShape Lifesciences (RSLS) Earnings FAQs
ReShape Lifesciences (RSLS) last reported earnings on May 15, 2024 for Q1 2024, posting an EPS of -$130.50, which Beat the estimate of -$232 by 43.75%.
For Q1 2024, ReShape Lifesciences (RSLS) reported an EPS of -$130.50, exceeding analysts' estimate of -$232 by 43.75%.
For Q1 2024, ReShape Lifesciences (RSLS) Beat expectations with an actual EPS of -$130.50 vs. an estimated EPS of -$232.
Following the last earnings report on May 15, 2024, ReShape Lifesciences (RSLS)'s stock price moved — from — to —.
The next ReShape Lifesciences (RSLS) earnings call is scheduled for Aug. 14, 2025, where executives will discuss financial results and outlook.